ZYBT

Upgrade to FINVIZ Elite to get real-time quotes, intraday charts, and advanced charting tools. Subscribe to Elite

Index	-	P/E	-	EPS (ttm)	-0.06	Insider Own	90.66%	Shs Outstand	47.39M	Perf Week	1.77%
Market Cap	54.03M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	4.43M	Perf Month	-45.75%
Enterprise Value	68.58M	PEG	-	EPS next Q	-	Inst Own	0.33%	Short Float	0.69%	Perf Quarter	-57.72%
Income	-2.67M	P/S	2.53	EPS this Y	-	Inst Trans	-0.59%	Short Ratio	0.70	Perf Half Y	-80.48%
Sales	21.33M	P/B	1.31	EPS next Y	-	ROA	-3.88%	Short Interest	0.03M	Perf YTD	0.00%
Book/sh	0.88	P/C	8.12	EPS next 5Y	-	ROE	-6.63%	52W High	14.30 -91.96%	Perf Year	-76.34%
Cash/sh	0.14	P/FCF	771.86	EPS past 3/5Y	-36.18% -	ROIC	-6.29%	52W Low	1.11 3.60%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-7.94% -	Gross Margin	35.97%	Volatility	5.96% 8.30%	Perf 5Y	-
Dividend TTM	-	EV/Sales	3.22	EPS Y/Y TTM	-194.62%	Oper. Margin	-17.67%	ATR (14)	0.14	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.01	Sales Y/Y TTM	-18.78%	Profit Margin	-12.50%	RSI (14)	20.32	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	1.49	EPS Q/Q	-338.11%	SMA20	-24.42%	Beta	-4.61	Target Price	-
Payout	-	Debt/Eq	0.29	Sales Q/Q	-34.71%	SMA50	-40.01%	Rel Volume	0.74	Prev Close	1.14
Employees	277	LT Debt/Eq	0.02	Earnings	-	SMA200	-79.23%	Avg Volume	44.15K	Price	1.15
IPO	Jan 07, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	32,698	Change	0.88%

Jul-03-25 08:30AM	Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results (PR Newswire)
May-23-25 04:05PM	Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F (GlobeNewswire) -12.33%
Jan-14-25 12:00PM	Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option (GlobeNewswire)
Jan-08-25 12:00PM	Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering (GlobeNewswire) -7.41%
Jan-06-25 05:50PM	Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering (GlobeNewswire)

Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. It offers a range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company was founded on March 24, 2023 and is headquartered in Jilin City, China.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Vanguards Skyline Holdings Lim	Shareholder	Nov 01 '25	Proposed Sale	12.91	2,278,752	29,419,666		Oct 22 04:10 PM
VVAX Holdings Limited	Shareholder	Nov 01 '25	Proposed Sale	2.62	684,996	1,794,690		Oct 22 04:10 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Zhengye Biotechnology Holding Ltd

Upgrade your FINVIZ experience